Adding immunotherapy to platinum-gemcitabine chemotherapy can improve outcomes in patients with advanced urothelial carcinoma, but that may depend on the platinum agent used, data suggest.

During the first decade of the Affordable Care Act (ACA), survival and mortality increased among young adults with cancer who were eligible for dependent care e ...

Safety results and AE management approaches for talquetamab were reported by oncology nurses practicing at study sites participating in the MonumenTAL-1 studies.

Recently, it has been demonstrated that in B-ALL, distinct developmental states are associated with genomic alterations and clinical characteristics.

Researchers found that patients diagnosed with HCC during 2013-2019 were less likely to die from HCC or from any cause than patients who were diagnosed during 2006-2012.